Description

CAVASOL® cyclodextrins are a range of chemically modified α, β and γ cyclodextrins, i.e. cyclodextrin derivatives. The main commercial products are hydroxypropyl-modified α, β and γ-cyclodextrins and methylated β-cyclodextrins. The main benefit of this modification is to significantly increase solubility in aqueous media. CAVASOL® cyclodextrin derivatives are primarily used for the controlled release of pharmaceuticals, increasing the solubility of cyclodextrin/drug complexes in the body. The increased bioavailability of the pharmaceutical active means it is absorbed faster and more extensively in the body.

Features

  • Complexing Agent
  • Microencapsulation agent

How can we help you with CAVASOL?

I am looking for...